Director Mattaj comments on the Nobel Prize for Chemistry 2020
Director Iain Mattaj commented the winners of the 2020 Nobel Prize for Chemistry: “The Nobel prize awarded to Charpentier and Doudna is very well deserved. CRISPR is a typical example of a discovery which initially seemed interesting to a limited, niche group of scientists studying bacterial evolution. It has since become a fundamental tool for biology and subsequently an experimental tool for therapies linked to human health.
Genetic engineering, first achieved in 1972, is the ability to manipulate the structure and composition of DNA molecules by “cutting and pasting”. It allows us to learn what genes do, how they work and why they go wrong.
CRISPR technology has the potential to make the “dream” of genetic engineering come true: to make specific, targeted changes in the genome of any organism.
Since the breakthrough of Charpentier and Doudna, thousands of experiments have been published showing that CRISPR systems work to enable “cut and paste” experiments in the genomes of a large variety of organisms, including human cells and organoids in culture. Off-target side effects are limited and can be measured and controlled. This progress is already enabling clinical trials of the use of CRISPR in certain types of cancer treatment. Once its safety is established, the method will be applicable to many genetic disease states, and also potentially to treat parasites that infect or damage humans, like viruses.
Meanwhile, researchers are applying the method to a wide variety of questions. At Human Technopole for example, we are using it to help understand neurodevelopmental disorders, to identify promising drug targets in different cancers and to understand aspects of the evolution of the brain.”
Image credit: Nobel Media. Ill. Niklas Elmehed.
Share:
You could also like:
-
Mapping all cancers’ weaknesses
Scientists from some of the world’s leading genomics research centres launch a call to action to build the “Cancer Dependency Map”, a map to chart genes linked to tumour survival and identify drug targets. The call the action is published today in Nature and has among its supporters Francesco Iorio, bioinformatician, group leader of the […]
-
Science is a collaborative endeavour
In January 2019, the arrival of Director Iain Mattaj marked the beginning of the Human Technopole Foundation. Since then, we have made great progress, structuring our administrative offices, refurbishing existing buildings and creating new spaces for our first experimental laboratories. The global pandemic which hit the world in 2020 caused unimaginable difficulties and loss to people all over the world, forcing us […]
-
MoU between HT and Associazione Civita
Human Technopole and Associazione Civita kick off the new year by signing a memorandum of understanding to carry out joint activities to promote scientific culture and dissemination of knowledge. HT is the new Italian research institute for life sciences. As part of its mission, HT aims to contribute to the advancement of scientific knowledge and […]
-
Keeping Sperm Cells on Track
One essential component of each eukaryotic cell is the cytoskeleton. Microtubules, tiny tubes consisting of a protein called tubulin, are part of this skeleton of cells. Cilia and flagella, which are antenna-like structures that protrude from most of the cells in our body, contain many microtubules. An example of flagell is the sperm tail, which is essential […]
-
Happy holidays from Human Technopole!
We have reached the end of a year which has been intense and complicated for Italy and the entire world. Despite the difficulties that hit, including the city of Milan, for Human Technopole 2020 was a year of great growth and development: we are on the verge of one hundred employees and over forty recruitment […]